# Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

> **NCT07190690** · NA · RECRUITING · sponsor: **Fundación EPIC** · enrollment: 2100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** ihtDEStiny® DES implanted
- **DEVICE:** Xience™ DES implanted

## Key facts

- **NCT ID:** NCT07190690
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-19
- **Primary completion:** 2029-10-15
- **Final completion:** 2030-10-15
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190690, "Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07190690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*